JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2015, Vol. 29 ›› Issue (1): 12-14.doi: 10.6040/j.issn.1673-3770.0.2014.242

Previous Articles     Next Articles

Treatment of palatal myoclonus objective tinnitus guided by palatal electromyogram

WANG Tan, AN Feng-wei, CHEN Jian-qiu, LIN Jia-feng, HOU Xiao-zhi, XIE Cui-li, WANG Ying, LIN Juan   

  1. Department of Otolaryngology & Head and Neck Surgery, General Hospital of Jinan Military Region, Jinan 250031, Shandong, China
  • Received:2014-07-23 Online:2015-02-16 Published:2015-02-16

Abstract: Objective To observe the clinical efficacy of botulinum toxin typeA(BTX-A) in the treatment of palatal myoclonus objective tinnitus(PMOT)under the guidance of palatal electromyography(P-EMG). Method The clinical data of 3 bilateral PMOT patients were reviewed. With endoscopic assistance, the disposable hypodermic needle electrode was inserted at the initiation site of tensor veli palatine(TVP), levator veli palatine(LVP), and termination site of LVP through nasal cavity. The direction and depth of the electrodes were adjusted according to the denseness of electric potential outbreak in the EMG diagram d. The superficial site, with the most dense electric potential outbreak was chosen as the point for injection. At each point, 5U BTXA was injected every time and the total amount was 30U . The therapeutic effects and adverse reaction were observed for 6 months afterthe injection. Result ① Therapeutic effectiveness: The PMOT was disappeared 26 h, 25 h and 28 h after the injection in 3 patients, respectively. None of positive expressions was observed in monthly endoscopic examination, P-EMG, and acoustic immittance examination 5 months after the injection. Recurrence of unilateral tinnitus was noted in only one patient.② Adverse reaction :The side effects, such as open rhinolalia, mild nasal regurgitation and mild ear stuffiness with tinnitus, were identified, but disappeared 2 weeks later afterthe treatment. Conclusion Using P-EMG during BTXA injection can accurately determine the site for injection, extend the action time of BTXA, reduce the adverse reaction, and achieve a good clinical results.

Key words: Tensor veli palatine, Palatal electromyography, Levator veli palatine, Botulinum toxin typeA, Palatal myoclonus objective tinnitus

CLC Number: 

  • R764.45
[1] Varney S M, Demetroulakos J L, Fletcher M H, et al. Palatal myoclonus: treatment with Clostridium botulinum toxin injection[J]. Otolaryngol Head Neck Surg, 1996, 114(2):317-320.
[2] Le Pajolec C, Marion M H, Bobin S. Objective tinnitus and palatal myoclonus. A new therapeutic approach[J]. Ann Otolaryngol Chir Cervicofac, 1990, 107(6):363- 365.
[3] Seidman M D, Arenberg J G, Shirwany N A. Palatal myoclonus as a cause of objective tinnitus: a report of six cases and a review of the literature[J]. Ear Nose Throat J, 1999, 78(4):292- 294, 296- 297.
[4] Su C Y, Hsu S P, Chee E C. Electromyographic recording of tensor and levator veli palatini muscles: a modified transnasal insertion method[J]. Laryngoscope, 1993,103(4):459-462.
[5] Chien H F, Sanchez T G, Sennes L U, et al. Endonasal approach of salpingopharyngeus muscle for the treatment of ear click related to palatal tremor[J]. Parkinsonism Relat Disord, 2007, 13:254-256.
[6] 管进,林顺涨,范静平,等.A型肉毒毒素在面颈部肌痉挛的应用[J]. 临床耳鼻咽喉头颈外科杂志,2008,22(24):1143-1144. GUAN Jin, LIN Shunzhang, FAN Jingping, et al. Application of botulinum toxin A in the treatment of facial and neck muscles spasm[J]. J Clin Otorhinolaryngol Head Neck Surg, 2008, 22(24):1143-1144.
[7] 姜平.咽鼓管和腭帆提肌、腭帆张肌的解剖关系[J].解剖学杂志,1991,14(3):199-202. JIANG Ping. Anatomy relationships between the levator and tensor veli palatine muscles and eustachian tube[J]. Chin J Anatomy, 1991, 14(3):199-202.
[8] Hambleton P. Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use[J]. J Neurol, 1992, 239(1):16- 20.
[9] 刘军,王洪田,韩冰,等.应用肉毒毒素A治疗腭肌阵挛性耳鸣的临床分析[J].听力学及言语疾病杂志,2006,14(3):190-192. LIU Jun, WANG Hongtian, HAN Bing, et al.The Use of Botulinum Toxin A in the Treatment of Palatal Myoclonus Tinnitus[J]. J Audiol Speech Pathol, 2006, 14(3):190-192.
[1] CAO Xiao-ping, WANG Tian-sheng, GU Dong-sheng, HUANG Ai-ping.. Tinni TestTM and high stimulus rate auditory brainstem response in  patients with normal hearing [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2012, 26(4): 6-9.
[2] WEI Tingting1, ZHAO Dean1, GAO Xingqiang1, SU Wenling1, ZHU Yanshuang1, ZHAO Yan2. Expression of Arc/arg3.1 in the auditory brainstem of rats with tinnitus induced by sodium salicylate [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2010, 24(01): 21-24.
[3] BAI Yanxia, WANG Xuan
. Clinical value of the acoustic reflex in patients with myasthenia gravis [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2009, 23(1): 46-47 .
[4] ZHU Ya-jiao, XUE Fei, WANG Qiu-ping. Psychoacoustic characteristics of 90 tinnitus patients [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(5): 14-17.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!